Bio-Techne
TECH
#1486
Rank
NZ$20.55 B
Marketcap
$129.38
Share price
2.49%
Change (1 day)
4.79%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$0.70 Billion

According to Bio-Techne's latest financial reports the company's total debt is NZ$0.70 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30NZ$0.74 B43.21%
2022-06-30NZ$0.52 B-12.97%
2021-06-30NZ$0.60 B-10.8%
2020-06-30NZ$0.67 B-10.25%
2019-06-30NZ$0.75 B50.12%
2018-06-30NZ$0.50 B6.44%
2017-06-30NZ$0.47 B251.72%
2016-06-30NZ$0.13 B18.73%
2015-06-30NZ$0.11 B663.45%
2014-06-30NZ$14.75 M
2006-06-30NZ$22.01 M4.95%
2005-06-30NZ$20.97 M-16.11%
2004-06-30NZ$24.99 M-14.82%
2003-06-30NZ$29.34 M-20.98%
2002-06-30NZ$37.14 M-20.26%
2001-06-30NZ$46.57 M10.75%
2000-06-30NZ$42.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$62.44 B 8,752.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.45 B 247.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.55 B 4,941.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.98 B 4,292.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.39 B 381.26%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$35.22 B 4,894.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.2 M-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA